FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CDER Continues Quality Management Program

[ Price : $8.95]

Federal Register notice: FDA seeks drug manufacturing establishments to participate in the second year of its voluntary Quality Ma...

FDA Integrity, Decision-Making at Risk: Blog

[ Price : $8.95]

FDA Matters founder Steven Grossman says FDA commissioner Martin Makary and the Trump administration are at a crossroads and need ...

ICH Q1 Stability Testing Guide Out for Comment

[ Price : $8.95]

The International Council for Harmonization endorses and releases for comment its Q1 guidance on drug product stability testing.

FDA Alert on Compounded Topical Finasteride

[ Price : $8.95]

FDA says it has received reports of adverse effects associated with using unapproved compounded topical finasteride products.

Drug Promotion Leaders Leave Agency

[ Price : $8.95]

FDA Office of Prescription Drug Promotion director Catherine Gray and deputy director Mark Askine resign their posts in the wake ...

QS Violations at Noah Medical Corporation

[ Price : $8.95]

FDA warns San Jose, CA-based Noah Medical about Quality System violations in its manufacturing of the Galaxy System bronchoscopes ...

Promising Enhertu+Perjeta Data in Breast Cancer

[ Price : $8.95]

AstraZeneca and Daiichi Sankyo report interim data from a Phase 3 trial that showed Enhertu (trastuzumab deruxtecan), in combinati...

Lt. Governors Urge Trump to Support FDA, Other Agencies

[ Price : $8.95]

The Democratic Lieutenant Governors Association writes president Donald Trump urging him to support and safeguard the integrity of...

Digital Health Technologies an FDA Priority: Article

[ Price : $8.95]

Three FDA staffers discuss the agencys efforts to advance the use of digital health technologies in clinical trials.

Makary Says FDA Exploring Conditional Approvals

[ Price : $8.95]

FDA commissioner Marty Makary says the agency is exploring the use of a new drug approval pathway for rare diseases and incurable ...